Background Enrolling participants onto clinical trials of cancer presents an important
challenge. We aimed to identify the concerns of patients with cancer about, and the barriers …

Background Patient participation in clinical trials is vital for knowledge advancement and
outcomes improvement. Few adult cancer patients participate in trials. Although patient …

Background Clinical trials are the principal means by which new treatment approaches are
evaluated in medicine. It has been argued that randomised clinical trials provide the highest …

OBJECTIVE: To investigate the barriers, modifiers, and benefits involved in participating in
randomized controlled trials of cancer therapies as perceived by health care providers and …

Background Recruitment to clinical trials can be challenging and slower than anticipated.
This prospective patient survey aimed to investigate the proportion of patients approached …

Background Clinical trials are vital for evidence-based cancer care. Oncologist engagement
in clinical trials has an effect on patient recruitment, which in turn can affect trial success …

Objective Clinical trials have long been considered the 'gold standard'of research generated
evidence in health care. Patient recruitment is an important determinant in the success of the …

Why patients don't take part in cancer clinical trials: an overview of the literature Clinical
trials have been recognized extensively within the literature as a crucial component in the …

Background Barriers to cancer clinical trial participation have been the subject of frequent
study, but the rate of trial participation has not changed substantially over time. Studies often …

It is necessary to carry out randomised clinical cancer trials (RCT s) in order to evaluate new,
potentially useful treatments for future cancer patients. Participation in clinical trials plays an …